

| Package | Price per Dose | Price | |
|---|---|---|---|
| 360 pills | £0.68 | £288.65 £245.36 Free shipping | |
| 180 pills | £0.73 | £153.68 £130.62 | |
| 120 pills | £0.78 | £110.91 £94.27 | |
| 90 pills | £0.82 | £86.85 £73.83 | |
| 60 pills | £0.86 | £61.46 £52.24 | |
| 30 pills | £0.90 | £32.06 £27.25 | |
| 180 pills | £1.08 | £228.52 £194.24 Free shipping | |
| 120 pills | £1.14 | £160.36 £136.30 | |
| 90 pills | £1.23 | £129.62 £110.18 | |
| 60 pills | £1.34 | £94.87 £80.64 | |
| 30 pills | £1.47 | £52.11 £44.29 | |
| 180 pills | £1.78 | £378.20 £321.47 Free shipping | |
| 120 pills | £1.87 | £264.60 £224.91 Free shipping | |
| 90 pills | £2.00 | £211.14 £179.47 Free shipping | |
| 60 pills | £2.16 | £152.34 £129.49 | |
| 30 pills | £2.45 | £86.85 £73.83 | |
| 90 pills | £2.89 | £306.03 £260.12 Free shipping | |
| 60 pills | £3.08 | £217.82 £185.15 Free shipping | |
| 30 pills | £3.77 | £133.63 £113.58 |
Disclaimer: This information is for adults in the United Kingdom and is not a substitute for medical advice. Consult a healthcare professional for personalised guidance and for any questions about Endep (amitriptyline).
Could low mood or depressive symptoms be linked with ongoing nerve pain, such as burning or shooting sensations in the limbs?
Endep is the brand name for amitriptyline, a medication classed as a tricyclic antidepressant (TCA). It is used to treat certain mood disorders and a selection of chronic pain conditions.
The exact mechanism by which amitriptyline relieves pain is not the same as the mechanism for improving mood, but both effects can be related to influencing nerve signalling in the brain and spinal cord. In routine clinical use, Endep is prescribed when mood symptoms coexist with painful conditions or when pain persists despite standard treatments.
Therapeutic choices are guided by the individual's medical history, current medications, and potential risks. The prescriber will assess whether Endep is appropriate and will monitor response and tolerability over time.
When Endep is used for mood disorders or pain, regular follow-up is important to determine effectiveness, manage side effects, and determine the duration of treatment. Should any new symptoms arise, a healthcare professional should be contacted promptly.
Endep belongs to the class of medicines known as tricyclic antidepressants (TCAs). They work by altering the balance of neurotransmitters in the brain, notably serotonin and noradrenaline, to improve mood and affective symptoms.
The use of Endep for depression is established in clinical practice, and it may be chosen when other treatments have not provided sufficient relief or when coexisting pain is present. It is important to note that antidepressants require persistent use for an adequate period to assess benefit.
As with other antidepressants, the onset of mood improvement may take several weeks. During this period, monitoring for response and tolerability is essential, and any concerns should be discussed with the prescribing clinician.
Endep possesses anticholinergic properties that can contribute to side effects such as dry mouth, constipation, and blurred vision in some individuals. These effects vary between people and often lessen with continued therapy or dose adjustments under supervision.
In certain situations, amitriptyline may be used off-label for mood stabilization or anxiety disorders, but the primary and approved indications should be confirmed by the patient’s physician. If there is any doubt, consult the official patient information leaflet or a pharmacist for clarification.
Neuropathic pain refers to pain caused by nerve damage or nerve dysfunction, often described as burning, tingling, or electric shock-like sensations. Endep can be prescribed as part of a broader pain management plan when neuropathic pain is present.
In fibromyalgia and other chronic pain syndromes, Endep may help reduce pain intensity and improve sleep quality, which can contribute to overall functioning. The effectiveness for pain relief varies among individuals and may require a gradual titration under medical supervision.
Because amitriptyline can cause sedation, dizziness, or cognitive effects in some patients, dosing is tailored to balance pain control with daytime functioning. Regular review is recommended to evaluate benefits versus potential adverse effects.
When used for pain, Endep is often considered after other non-pharmacological strategies and non-opioid analgesics have been explored. It is not a cure for underlying nerve disorders but can improve quality of life when used as part of a comprehensive care plan.
In elderly patients, starting at a low dose and careful monitoring for falls, confusion, or urinary retention is important. Those with a history of glaucoma or urinary problems should discuss risks with the prescriber before commencing therapy.
Amitriptyline is commonly employed off-label for preventing migraine attacks in some patients. When used for this purpose, Endep can reduce the frequency and severity of migraine episodes in certain individuals.
Response to migraine prophylaxis typically requires several weeks of consistent treatment. If headaches persist or worsen after an adequate trial period, the prescriber will reassess the treatment plan and may adjust the dose or consider alternative therapies.
Because of sedative effects, some patients notice improved sleep which may indirectly influence migraine patterns. The benefit-to-risk balance should be evaluated with a clinician, taking into account daytime function and potential anticholinergic effects.
Endep is one of several options for migraine prevention. Other medications and non-pharmacological strategies may be considered, depending on the patient’s history, comorbidities, and treatment response. Always consult the prescribing clinician before starting new therapies for migraine.
Like all preventive therapies, stopping Endep abruptly can worsen symptoms or provoke withdrawal-like effects. Any changes to the regimen should be performed under medical supervision with a gradual taper if advised.
In simple terms, amitriptyline increases the levels of neurotransmitters in the brain that regulate mood, sleep, and pain perception. By inhibiting the reuptake of serotonin and noradrenaline, it prolongs their activity in nerve synapses and circuits involved in emotion and pain signaling.
Pharmacologically, amitriptyline also interacts with several other receptor systems, including those for acetylcholine, histamine, and norepinephrine. These interactions contribute to both therapeutic effects and side effects such as sedation and dry mouth.
From a detailed pharmacodynamic perspective, amitriptyline modulates neuronal excitability and pain transmission at multiple levels of the central nervous system. This involves descending pain modulation pathways and changes in cortical processing that can reduce pain signals and improve sleep, which can in turn influence mood and daytime functioning.
In terms of pharmacokinetics, amitriptyline is absorbed orally and extensively metabolised in the liver to active and inactive metabolites. The duration of action depends on tissue distribution and metabolic clearance, which can vary between individuals due to genetic factors, age, and concomitant medications.
Overall, the analgesic and antidepressant benefits arise from a combination of monoaminergic effects and neuromodulatory actions in central nervous system circuits, rather than a single mechanism. If any concerns arise about mechanism with respect to a patient’s specific condition, a pharmacist or prescriber should be consulted for clarification.
Endep is typically prescribed after a careful assessment of the patient’s medical history, other medications, and potential interactions. Dosing is individualized to balance therapeutic effect with tolerability and safety.
In clinical practice, patient instructions often include taking Endep at night because of possible drowsiness. The timing can be adjusted by the clinician to suit sleep patterns and daytime activities. Evaluations of response are usually conducted over several weeks.
Starting with a low dose and gradually increasing, under medical supervision, helps minimise side effects such as sedation, dry mouth, constipation, or dizziness. Any changes to the dosing schedule should be made only after professional guidance.
Medication reviews should occur if new medicines are started, existing ones are stopped, or if there is a change in health status. Careful monitoring is particularly important in older adults and those with liver or kidney impairment, as these factors can affect drug handling in the body.
For patients with symptomatic relief from pain but concomitant mood symptoms, coordinated management with other professionals (for example, physiotherapists or pain specialists) may enhance overall outcomes. Self-initiation or discontinuation without professional advice is not recommended.
Endep may not be suitable for everyone. A complete medical history is required to evaluate contraindications, potential drug interactions, and safety risks. Certain conditions or recent events may reduce the utility of amitriptyline or require alternative therapies.
Common adverse effects include drowsiness, dry mouth, constipation, blurred vision, and dizziness. Many of these side effects lessen with continued use or dose adjustment under professional supervision.
Serious adverse effects are uncommon but may include severe allergic reactions, significant changes in mood or behaviour, fast heart rate, severe confusion, or chest pain. Seek urgent medical help if such symptoms occur.
Endep can interact with a range of medicines, including certain antidepressants, anticholinergic agents, and medicines that affect heart rhythm. A detailed drug history is essential prior to starting Endep, and all potential interactions should be reviewed with a pharmacist or prescriber.
Contraindications include known hypersensitivity to amitriptyline, a recent heart attack in the absence of medical approval, and certain conditions where arrhythmias or conduction disturbances are present. More information is available in the official patient information leaflet provided with the medicine and from a healthcare professional.
In pregnancy, Endep may be considered only if the potential benefits justify potential risks to the fetus. The decision is made by the treating clinician after thorough assessment. Alternative therapies may be preferred depending on the clinical scenario.
Breastfeeding while taking amitriptyline is a consideration that requires occupational and infant safety assessment. The drug can pass into breast milk, and the potential effects on the infant should be discussed with a clinician.
In elderly patients, careful monitoring for cognitive changes, dizziness, risk of falls, and anticholinergic effects is recommended. Dose adjustments and slower uptitration may be necessary to maintain safety and tolerability.
Severe liver impairment can alter amitriptyline metabolism. In such cases, dosing and monitoring instructions will be tailored by the prescriber. If liver function changes or symptoms occur, medical advice should be sought promptly.
Patients with glaucoma, urinary retention, or a history of seizures may require additional assessment before initiating Endep. The full safety profile should be reviewed with a healthcare professional before treatment begins.
Endep can interact with several classes of medications, including other antidepressants, anticholinergic drugs, certain antiarrhythmics, and medicines affecting glucose or liver enzymes. A complete list of current medicines should be provided to the prescriber or pharmacist before starting Endep.
Concomitant use with alcohol is discouraged, as it can enhance sedation and impair coordination. Safety in daily activities may be affected, particularly at the start of treatment or after dose changes.
When combined with medicines that affect heart rhythm, a clinician will consider potential risks. ECG monitoring or dose adjustments may be recommended in some cases, especially for individuals with pre-existing heart conditions.
In cases of acute illness, dehydration, or electrolyte imbalance, the safety of Endep may be impacted. Medical advice should be sought to determine whether continued use is appropriate temporarily during such events.
If any new medications are prescribed or existing therapies changed, a pharmacist should be consulted to assess potential interactions with Endep. The goal is to maintain efficacy while minimising adverse effects and safety concerns.
Regular follow-up with a clinician is recommended to assess therapeutic response, tolerability, and any emerging safety concerns. Adjustments to the regimen may be necessary based on clinical progress and changes in health status.
Long-term use requires periodic review to determine ongoing need, potential withdrawal risks, and the possibility of tolerance or reduced effectiveness. Tapering off Endep should be performed under professional guidance to minimise withdrawal symptoms.
Discontinuation should never be abrupt unless advised by a clinician. A gradual taper reduces the risk of withdrawal symptoms such as mood changes, sleep disturbances, or flu-like sensations.
In the presence of persistent or worsening symptoms, or new mental health concerns, prompt medical consultation is advised. The information provided here is not a substitute for ongoing clinical care and monitoring.
Storage and disposal guidelines should be followed as stated in the patient information leaflet. Keeping Endep out of reach of children and away from household exposure is essential for safety.
The following Q&A pairs address common patient questions. Answers are cautious and avoid fixed dosing recommendations. Always follow the prescribing clinician’s directions and the official patient information leaflet.
Yes, Endep can be started in individuals who have not previously used a tricyclic antidepressant, but a clinician will assess the risk-benefit ratio. Tolerability and response are monitored closely after initiation.
If a dose is missed, it should be taken as soon as remembered unless it is almost time for the next dose. Do not double the dose to make up for a missed one without medical advice.
Improvements in mood or pain may take several weeks. If no improvement is observed after an adequate trial period, a clinician may reassess treatment, including dose adjustments or alternative therapies.
Most foods do not interact strongly with amitriptyline, but alcohol can increase sedation. It is prudent to limit alcohol consumption while taking Endep and to discuss any dietary concerns with a pharmacist or clinician.
Pregnancy safety depends on individual circumstances. The potential benefits and risks must be weighed by the clinician, and alternatives may be considered. Seek guidance from a healthcare professional if pregnancy is planned or suspected.
Long-term use may be appropriate for some patients under regular medical supervision. Periodic review is essential to determine ongoing need, evaluate safety, and plan for eventual discontinuation if appropriate.
Any new health issues or starting/stopping other medications should be discussed with a prescriber or pharmacist to assess potential interactions and adjust therapy as needed.
Severe allergic reactions, chest pain, significant mood changes, or severe confusion require urgent medical attention. If such symptoms occur, seek medical help promptly.
Endep can be effective for neuropathic pain in certain individuals. Efficacy varies, and some patients may respond better to other agents. A clinician will tailor therapy based on pain intensity, mood symptoms, comorbid conditions, and prior responses.
Monitoring commonly includes assessment of mood, pain, sleep, tolerance of side effects, and any signs of adverse reactions. Blood pressure and pulse may be observed if dizziness or falls are a concern.
Some individuals may experience drowsiness or slowed reaction times, especially early in treatment or after dose changes. Avoid driving or operating heavy machinery if these effects occur.
A careful assessment is necessary in older adults due to increased risk of dizziness, confusion, and falls. Dose initiation is often conservative with gradual titration and closer monitoring.
Discontinuation should be managed by a clinician. A gradual tapering plan is usually advised to minimise withdrawal symptoms and symptom recurrence. Do not stop abruptly without professional guidance.
14–21 days. Free from £151.46 .
5–9 days. £22.72
−10% when paying with cryptocurrency.
−10% on all repeat orders.
All orders are packed in neutral, unbranded boxes with no product name on the outside.
